Australia vs South Africa: Previously treated cases tested for RR-/MDR-TB
Australia
76.0%
in 2024
South Africa
77.0%
in 2024
Australia rank
120th
South Africa rank
118th
Previously treated cases tested for RR-/MDR-TB over time
- Australia
- South Africa
How they compare
South Africa currently reports 77.0% against 76.0% in Australia, a difference of 1.0%.
The two have swapped places 2 times across 8 shared years of data; in 2015 it was South Africa ahead.
Australia ranks 120th and South Africa ranks 118th of 180 countries.
South Africa has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Australia | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 71.7% | 75.7% | 4.0% | South Africa |
| 2020s | 73.2% | 91.8% | 18.6% | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Australia or South Africa?
- South Africa, at 77.0% against 76.0% in Australia as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Australia and South Africa?
- 1.0%, with South Africa ahead.
- How many years of comparable data are there for Australia and South Africa?
- 8 years are reported by both, from 2015 to 2024.
- How do Australia and South Africa rank globally for previously treated cases tested for rr-/mdr-tb?
- Australia ranks 120th and South Africa ranks 118th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.